US Stock MarketDetailed Quotes

OMIC Singular Genomics

Watchlist
  • 19.600
  • +0.180+0.93%
Close Dec 27 16:00 ET
49.66MMarket Cap-0.57P/E (TTM)

Singular Genomics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-17.69%-19.79M
9.80%-18.04M
-32.17%-23.7M
15.44%-73.65M
5.10%-18.9M
22.83%-16.81M
21.74%-20M
9.60%-17.93M
-68.46%-87.09M
-26.87%-19.92M
Net income from continuing operations
24.89%-16.8M
16.91%-21.25M
-5.89%-25.02M
-4.34%-94.82M
-10.18%-23.25M
6.01%-22.36M
-6.65%-25.58M
-7.39%-23.63M
7.99%-90.88M
-6.79%-21.1M
Operating gains losses
----
----
----
----
----
----
----
----
-97.36%60K
----
Depreciation and amortization
-9.57%1.69M
-5.42%1.78M
-5.23%1.72M
19.74%7.22M
-3.89%1.65M
12.18%1.87M
22.05%1.88M
64.88%1.82M
432.39%6.03M
372.80%1.72M
Other non cash items
-182.49%-1.55M
21.21%40K
2.63%39K
2,329.70%4.01M
5,179.49%2.06M
3,897.87%1.88M
-21.43%33K
2.70%38K
-99.53%165K
8.33%39K
Change In working capital
-4,844.55%-5.22M
32.35%-548K
-358.33%-2.59M
86.65%-2.25M
58.78%-981K
103.08%110K
88.67%-810K
84.81%-564K
-477.71%-16.82M
-1,157.78%-2.38M
-Change in receivables
170.03%257K
-1,583.33%-303K
-52.39%428K
138.12%348K
81.82%-166K
---367K
---18K
--899K
---913K
---913K
-Change in inventory
97.73%-32K
25.62%-270K
-258.84%-1.32M
73.77%-3.54M
-948.69%-2.6M
68.60%-1.41M
93.94%-363K
125.05%831K
---13.49M
--306K
-Change in prepaid assets
-220.18%-780K
78.36%-296K
60.14%1.65M
-16.06%507K
-81.72%195K
10.75%649K
49.28%-1.37M
-37.44%1.03M
108.82%604K
229.18%1.07M
-Change in payables and accrued expense
-17.94%837K
-43.20%718K
15.30%-2.73M
267.22%1.82M
200.25%2.77M
74.66%1.02M
-12.16%1.26M
-811.86%-3.23M
-123.99%-1.09M
-363.67%-2.76M
-Change in other current assets
-99.01%11K
--0
--72K
100.22%2K
-5,866.67%-1.04M
10,000.00%1.11M
-137.37%-71K
--0
14.89%-892K
113.95%18K
-Change in other current liabilities
-515.87%-5.51M
-56.30%-397K
-603.09%-682K
-33.27%-1.39M
-40.00%-140K
-229.04%-895K
-179.12%-254K
83.19%-97K
-332.14%-1.04M
-174.63%-100K
Cash from discontinued investing activities
Operating cash flow
-17.69%-19.79M
9.80%-18.04M
-32.17%-23.7M
15.44%-73.65M
5.10%-18.9M
22.83%-16.81M
21.74%-20M
9.60%-17.93M
-68.46%-87.09M
-26.87%-19.92M
Investing cash flow
Cash flow from continuing investing activities
271.21%42.29M
168.30%23.96M
-56.71%31.58M
134.90%13.81M
280.70%651K
35.19%-24.7M
-250.65%-35.09M
769.84%72.95M
69.76%-39.57M
100.73%171K
Net PPE purchase and sale
93.64%-7K
99.67%-1K
84.57%-25K
83.89%-970K
78.44%-392K
90.24%-110K
85.69%-306K
82.75%-162K
-23.81%-6.02M
-2.71%-1.82M
Net investment purchase and sale
272.00%42.3M
168.90%23.97M
-56.77%31.6M
144.05%14.78M
-47.56%1.04M
33.51%-24.59M
-342.04%-34.78M
683.99%73.11M
73.38%-33.54M
109.23%1.99M
Cash from discontinued investing activities
Investing cash flow
271.21%42.29M
168.30%23.96M
-56.71%31.58M
134.90%13.81M
280.70%651K
35.19%-24.7M
-250.65%-35.09M
769.84%72.95M
69.76%-39.57M
100.73%171K
Financing cash flow
Cash flow from continuing financing activities
0
-87.06%80K
0
-22.75%696K
-90.40%72K
0
511.88%618K
-73.91%6K
-99.76%901K
-7.41%750K
Net common stock issuance
----
----
--0
95.78%-19K
-117.14%-6K
----
----
36.36%-7K
-100.19%-450K
192.11%35K
Proceeds from stock option exercised by employees
--0
-86.91%80K
--0
-47.08%715K
-89.09%78K
-97.46%13K
578.89%611K
-61.76%13K
-69.06%1.35M
-15.68%715K
Cash from discontinued financing activities
Financing cash flow
--0
-87.06%80K
--0
-22.75%696K
-90.40%72K
--0
511.88%618K
-73.91%6K
-99.76%901K
-7.41%750K
Net cash flow
Beginning cash position
-59.86%30.72M
-81.14%24.71M
-77.84%16.83M
-62.34%75.98M
-63.13%35.01M
-50.58%76.53M
-31.17%130.99M
-62.34%75.98M
1,557.65%201.74M
-60.42%94.97M
Current changes in cash
154.21%22.51M
111.03%6.01M
-85.68%7.88M
52.97%-59.14M
4.30%-18.18M
30.66%-41.52M
-53.61%-54.47M
581.34%55.02M
-166.34%-125.76M
50.29%-19M
End cash Position
52.01%53.22M
-59.86%30.72M
-81.14%24.71M
-77.84%16.83M
-77.84%16.83M
-63.13%35.01M
-50.58%76.53M
-31.17%130.99M
-62.34%75.98M
-62.34%75.98M
Free cash flow
-16.97%-19.8M
11.16%-18.04M
-31.12%-23.73M
19.87%-74.62M
11.23%-19.29M
26.14%-16.92M
26.67%-20.3M
12.91%-18.1M
-64.62%-93.12M
-24.42%-21.74M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -17.69%-19.79M9.80%-18.04M-32.17%-23.7M15.44%-73.65M5.10%-18.9M22.83%-16.81M21.74%-20M9.60%-17.93M-68.46%-87.09M-26.87%-19.92M
Net income from continuing operations 24.89%-16.8M16.91%-21.25M-5.89%-25.02M-4.34%-94.82M-10.18%-23.25M6.01%-22.36M-6.65%-25.58M-7.39%-23.63M7.99%-90.88M-6.79%-21.1M
Operating gains losses ---------------------------------97.36%60K----
Depreciation and amortization -9.57%1.69M-5.42%1.78M-5.23%1.72M19.74%7.22M-3.89%1.65M12.18%1.87M22.05%1.88M64.88%1.82M432.39%6.03M372.80%1.72M
Other non cash items -182.49%-1.55M21.21%40K2.63%39K2,329.70%4.01M5,179.49%2.06M3,897.87%1.88M-21.43%33K2.70%38K-99.53%165K8.33%39K
Change In working capital -4,844.55%-5.22M32.35%-548K-358.33%-2.59M86.65%-2.25M58.78%-981K103.08%110K88.67%-810K84.81%-564K-477.71%-16.82M-1,157.78%-2.38M
-Change in receivables 170.03%257K-1,583.33%-303K-52.39%428K138.12%348K81.82%-166K---367K---18K--899K---913K---913K
-Change in inventory 97.73%-32K25.62%-270K-258.84%-1.32M73.77%-3.54M-948.69%-2.6M68.60%-1.41M93.94%-363K125.05%831K---13.49M--306K
-Change in prepaid assets -220.18%-780K78.36%-296K60.14%1.65M-16.06%507K-81.72%195K10.75%649K49.28%-1.37M-37.44%1.03M108.82%604K229.18%1.07M
-Change in payables and accrued expense -17.94%837K-43.20%718K15.30%-2.73M267.22%1.82M200.25%2.77M74.66%1.02M-12.16%1.26M-811.86%-3.23M-123.99%-1.09M-363.67%-2.76M
-Change in other current assets -99.01%11K--0--72K100.22%2K-5,866.67%-1.04M10,000.00%1.11M-137.37%-71K--014.89%-892K113.95%18K
-Change in other current liabilities -515.87%-5.51M-56.30%-397K-603.09%-682K-33.27%-1.39M-40.00%-140K-229.04%-895K-179.12%-254K83.19%-97K-332.14%-1.04M-174.63%-100K
Cash from discontinued investing activities
Operating cash flow -17.69%-19.79M9.80%-18.04M-32.17%-23.7M15.44%-73.65M5.10%-18.9M22.83%-16.81M21.74%-20M9.60%-17.93M-68.46%-87.09M-26.87%-19.92M
Investing cash flow
Cash flow from continuing investing activities 271.21%42.29M168.30%23.96M-56.71%31.58M134.90%13.81M280.70%651K35.19%-24.7M-250.65%-35.09M769.84%72.95M69.76%-39.57M100.73%171K
Net PPE purchase and sale 93.64%-7K99.67%-1K84.57%-25K83.89%-970K78.44%-392K90.24%-110K85.69%-306K82.75%-162K-23.81%-6.02M-2.71%-1.82M
Net investment purchase and sale 272.00%42.3M168.90%23.97M-56.77%31.6M144.05%14.78M-47.56%1.04M33.51%-24.59M-342.04%-34.78M683.99%73.11M73.38%-33.54M109.23%1.99M
Cash from discontinued investing activities
Investing cash flow 271.21%42.29M168.30%23.96M-56.71%31.58M134.90%13.81M280.70%651K35.19%-24.7M-250.65%-35.09M769.84%72.95M69.76%-39.57M100.73%171K
Financing cash flow
Cash flow from continuing financing activities 0-87.06%80K0-22.75%696K-90.40%72K0511.88%618K-73.91%6K-99.76%901K-7.41%750K
Net common stock issuance ----------095.78%-19K-117.14%-6K--------36.36%-7K-100.19%-450K192.11%35K
Proceeds from stock option exercised by employees --0-86.91%80K--0-47.08%715K-89.09%78K-97.46%13K578.89%611K-61.76%13K-69.06%1.35M-15.68%715K
Cash from discontinued financing activities
Financing cash flow --0-87.06%80K--0-22.75%696K-90.40%72K--0511.88%618K-73.91%6K-99.76%901K-7.41%750K
Net cash flow
Beginning cash position -59.86%30.72M-81.14%24.71M-77.84%16.83M-62.34%75.98M-63.13%35.01M-50.58%76.53M-31.17%130.99M-62.34%75.98M1,557.65%201.74M-60.42%94.97M
Current changes in cash 154.21%22.51M111.03%6.01M-85.68%7.88M52.97%-59.14M4.30%-18.18M30.66%-41.52M-53.61%-54.47M581.34%55.02M-166.34%-125.76M50.29%-19M
End cash Position 52.01%53.22M-59.86%30.72M-81.14%24.71M-77.84%16.83M-77.84%16.83M-63.13%35.01M-50.58%76.53M-31.17%130.99M-62.34%75.98M-62.34%75.98M
Free cash flow -16.97%-19.8M11.16%-18.04M-31.12%-23.73M19.87%-74.62M11.23%-19.29M26.14%-16.92M26.67%-20.3M12.91%-18.1M-64.62%-93.12M-24.42%-21.74M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
0.00%
Petroleo Brasileiro SA Petrobras
PBR
-0.13%
Vale SA
VALE
-0.45%
Meta Platforms
META
-0.59%
Adobe
ADBE
-0.82%

Unlock the Full List